Treatment of Peri-implant Mucositis on Incongruous Dental Prostheses Versus Congruous

NCT ID: NCT05923554

Last Updated: 2023-06-28

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

56 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-05-25

Study Completion Date

2023-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the present study was to test the hypothesis that non-surgical periodontal therapy on peri-implant mucositis resolution results in a greater clinical improvement in patients with congruous versus non-congruous single dental implant restoration.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The aim of the present study was to test the hypothesis that non-surgical periodontal therapy on peri-implant mucositis resolution results in a greater clinical improvement in patients with congruous versus non-congruous single dental implant restoration by comparing two groups of patients with peri-implant mucositis.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Bleeding of Subgingival Space

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

After non-randomization, patients were assigned to a group with un-congruous single-tooth prostheses and a group with congruous single-tooth prostheses. Patients received a one-stage full-mouth scaling without chlorhexidine. Clinical and microbiological examination was performed at baseline, after 1, 2, and 3 months.
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Un-congruous single tooth peri implantitis

Patients were treated through non-surgical periodontal treatment for the peri-implant mucositis resolution

Group Type ACTIVE_COMPARATOR

Changes in Probing Depth to non-surgical periodontal therapy

Intervention Type OTHER

Changes in Probing Depth following non surgical periodontal treatment performed with hand and ultrasonic tips

Congruous single tooth peri implantitis

Patients were treated through non-surgical periodontal treatment for the peri implant mucositis resolution

Group Type PLACEBO_COMPARATOR

Changes in Probing Depth to non-surgical periodontal therapy

Intervention Type OTHER

Changes in Probing Depth following non surgical periodontal treatment performed with hand and ultrasonic tips

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Changes in Probing Depth to non-surgical periodontal therapy

Changes in Probing Depth following non surgical periodontal treatment performed with hand and ultrasonic tips

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* peri-implant mucositis
* bleeding on probing and/or a gingival index \<1 at least at one site at baseline
* absence of peri-implant bone loss during the last 2 years before baseline

Exclusion Criteria

* Periodontal disease
* Systemic diseases
Minimum Eligible Age

18 Years

Maximum Eligible Age

75 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Catania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Gaetano Isola

Researcher, Doctor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gaetano Isola

Role: PRINCIPAL_INVESTIGATOR

Università degli Studi di Catania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

AOU Policlinico G. Rodolico

Catania, , Italy

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Italy

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gaetano Isola

Role: CONTACT

0953785652

Rosalia Leonardi

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gaetano Isola, DDS

Role: primary

+3909537800

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-150-PO

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.